Comparison the Safety and Pharmacokinetic Characteristics of DWP422 25 mg With Those of ENBREL 25MG PFS INJ. After Subcutaneous Injection in Healthy Male Volunteers
Clinical trial NCT01635686 · UNKNOWN
Trial details
- NCT number
- NCT01635686
- Sponsor
- Daewoong Pharmaceutical Co. LTD.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-09-01
- Primary completion
- 2013-06-01
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.